Literature DB >> 2379451

Rapid in vitro bromodeoxyuridine labeling method for monitoring of therapy response in solid human tumors.

J Hemmer1.   

Abstract

In vitro bromodeoxyuridine (BrdUrd) incubated single-cell suspensions obtained from solid tumors were fixed on slides for subsequent sample processing. As dispersal of nuclei largely was avoided, only small amounts of cells were needed for examination. The sensitivity of detecting even low BrdUrd incorporation rates could be improved by treatment with intense DNA denaturation conditions. This technique was applied to monitor cytokinetic response to chemotherapy and radiation in oral carcinomas by analysing biopsies taken consecutively in the course of treatment. By combining BrdUrd labeling and DNA flow cytometry, cells arrested in S phase easily could be distinguished from cells showing continuous proliferation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2379451     DOI: 10.1002/cyto.990110507

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  5 in total

1.  Dose dependence of the cytokinetic and cytotoxic effects of epirubicin in vitro.

Authors:  D Bartkowiak; J Hemmer; E Röttinger
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

Review 3.  Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

4.  Effects of intralesional injection of cisplatin dissolved in urografin and lipiodol on Ehrlich ascites tumor and normal tissues of CD-1 mice.

Authors:  J E Landrito; K Yoshiga; K Sakurai; K Takada
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

5.  Flow cytometric analysis of early steps in development of adriamycin resistance in a human gastric cancer cell line.

Authors:  S Tanaka; K Aizawa; N Katayanagi; O Tanaka
Journal:  Jpn J Cancer Res       Date:  1994-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.